By integrating in vitro and in vivo models, and data from patients, this study unravels a novel molecular link between the homeobox HOXA9 gene and WNT6 in glioma, which has prognostic relevance in patients with highly aggressive GBMs. This evidence concerns the gene WNT6 and glioma.